BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $5.2 million in its first quarter.

The Beverly Hills, California-based company said it had a loss of 23 cents per share.

The biotechnology company posted revenue of $40,800 in the period. Its adjusted revenue was $41,000.

In the final minutes of trading on Thursday, the company's shares hit $3.16. A year ago, they were trading at $6.66.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News